Search

Nancy A Havrilla

from Olympia, WA
Age ~69
Get Report
Also known as:
Nancy Ann Havrilla, Nancy A Harvilla, Nancy A Haurilla
Phone and address:
3806 Kinsale Ln SE, Olympia, WA 98501
(360) 628-9897
Related to:
Neil Goldstein, 82Albert Havrilla, 92Linda M Bozowski, 77C Havrilla, 91Florence L Stein, 88C HavrillaLinda L Havrilla, 62
Connected to:
Jeromy J Havrilla, 51Kristin L Havrilla, 77Nicholas A Havrilla, 35Kelly A Havrish, 46Beverly A Havron, 62Ronald G Havron, 81Tyson C Havron, 42Natalie C Havrylik, 45Earnestine Havvard, 61Thi T Havy, 50

Nancy Havrilla Phones & Addresses

  • 3806 Kinsale Ln SE, Olympia, WA 98501 (360) 628-9897
  • Danville, CA
  • 2021 Carlton Ln, Placerville, CA 95667 (530) 344-1626 (530) 344-1662
  • Oakland, CA
  • 7251 Randolph St, Forest Park, IL 60130
  • South San Francisco, CA
  • Buffalo Grove, IL
  • Berkeley, CA
  • El Dorado, CA

Work

Company: Clinical consultant Jun 2015 Position: Owner

Education

Degree: Masters School / High School: Rush University 1989 to 1991 Specialities: Nursing

Skills

Clinical Development • Drug Development • Pharmaceutical Industry • Cro • Clinical Operations • Ctms • Drug Safety • Fda • Meddra • Biopharmaceuticals • Clinical Research Associates • Life Sciences • Infectious Diseases • Edc • Lifesciences • Sop • Clinical Monitoring • Protocol • Drug Discovery • Quality Assurance • Clinical Data Management • Therapeutic Areas • Ich Gcp • Gmp • Cancer • 21 Cfr Part 11 • Medical Devices • Pharmacology • Hematology

Industries

Biotechnology

Resumes

Resumes

Nancy Havrilla Photo 1

Owner

View page
Location:
3806 Kinsale Ln southeast, Olympia, WA 98501
Industry:
Biotechnology
Work:
Clinical Consultant
Owner
Myokardia 2014 - Jun 2015
Vice President Clinical Operations
Astex Pharmaceuticals Jul 2012 - Apr 2014
Executive Director, Clinical Operations
Ardea Biosciences Apr 2011 - Jul 2012
Senior Director, Clinical Operations
Achaogen Jul 2008 - Apr 2011
Senior Director, Clinical Operations
Education:
Rush University 1989 - 1991
Masters, Nursing Xavier College 1986 - 1989
Bachelors, Bachelor of Science, Nursing Muhlenberg Hospital School of Nursing 1974 - 1977
Springfield College 1973 - 1974
John P. Stevens High School 1969 - 1973
Skills:
Clinical Development
Drug Development
Pharmaceutical Industry
Cro
Clinical Operations
Ctms
Drug Safety
Fda
Meddra
Biopharmaceuticals
Clinical Research Associates
Life Sciences
Infectious Diseases
Edc
Lifesciences
Sop
Clinical Monitoring
Protocol
Drug Discovery
Quality Assurance
Clinical Data Management
Therapeutic Areas
Ich Gcp
Gmp
Cancer
21 Cfr Part 11
Medical Devices
Pharmacology
Hematology

Publications

Us Patents

Cd147 Binding Molecules As Therapeutics

View page
US Patent:
20070048305, Mar 1, 2007
Filed:
Feb 28, 2006
Appl. No.:
11/366003
Inventors:
C. Davis - Burlingame CA, US
Russell Blacher - Castro Valley CA, US
Jose Corvalan - Foster City CA, US
Alan Culwell - Carlsbad CA, US
Larry Green - San Francisco CA, US
Joanna Hales - Fremont CA, US
Nancy Havrilla - Oakland CA, US
Vladimir Ivanov - Fremont CA, US
John Lipani - Livermore CA, US
Qiang Liu - Foster CA, US
Richard Weber - San Francisco CA, US
Xiao-Dong Yang - Palo Alto CA, US
International Classification:
A61K 39/395
C07K 16/28
US Classification:
424144100, 530388220
Abstract:
In accordance with the present invention, we have discovered that the molecule CD147 as expressed on certain cells, such as T-cells, B-cells, and/or monocytes, can be utilized for the treatment of a variety of diseases. In particular, we have demonstrated that antibodies that bind to CD147 and that result in the killing of such cells, for example, through the binding of complement, is efficacious in the treatment of diseases. Diseases in which such treatment appears efficacious include, without limitation: graft versus host disease (GVHD), organ transplant rejection diseases (including, without limitation, renal transplant, ocular transplant, and others), cancers (including, without limitation, cancers of the blood (i.e., leukemias and lymphomas), pancreatic, and others), autoimmune diseases, inflammatory diseases, and others.

Cd147 Binding Molecules As Therapeutics

View page
US Patent:
20060104974, May 18, 2006
Filed:
Feb 15, 2001
Appl. No.:
09/784950
Inventors:
C. Davis - Burlingame CA, US
Russell Blacher - Castro Valley CA, US
Jose Corvalan - Foster City CA, US
Alan Culwell - Carlsbad CA, US
Larry Green - San Francisco CA, US
Joanne Hales - Fremont CA, US
Nancy Havrilla - Oakland CA, US
Vladimir Ivanov - Fremont CA, US
John Lipani - Livermore CA, US
Qiang Liu - Foster City CA, US
Richard Weber - San Francisco CA, US
Xiao-Dong Yang - Palo Alto CA, US
International Classification:
A61K 39/395
C07K 16/28
US Classification:
424144100, 530388220
Abstract:
In accordance with the present invention, we have discovered that the molecule CD147 as expressed on certain cells, such as T-cells, B-cells, and/or monocytes, can be utilized for the treatment of a variety of diseases. In particular, we have demonstrated that antibodies that bind to CD147 and that result in the killing of such cells, for example, through the binding of complement, is efficacious in the treatment of diseases. Diseases in which such treatment appears efficacious include, without limitation: graft versus host disease (GVHD), organ transplant rejection diseases (including, without limitation, renal transplant, ocular transplant, and others), cancers (including, without limitation, cancers of the blood (i.e., leukemias and lymphomas), pancreatic, and others), autoimmune diseases, inflammatory diseases, and others.
Control profile
Nancy A Havrilla from Olympia, WA, age ~69 Get Report